dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Pöördumine

Sotsiaalministeerium · 10. jaanuar 2025
Viit
5.1-3/80-1
Registreeritud
10. jaanuar 2025
Dokumendi liik
Sissetulev kiri
Adressaat
University of Latvia The Institute of Clinical and Preventive Medicine EUCanScreen Project Manager
Saabumis/saatmisviis
e-post/DVK
Funktsioon
5.1 Tervisekaitse, haiguste ennetamise ja tervise edendamise korraldamine
Sari
5.1-3 Tervise edendamise ja haiguste ennetamise kavandamise ja korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
5.1-3/2025
Vastutaja
Made Bambus (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Tervishoiuteenuste osakond)
Lahendamise tähtaeg
30. jaanuar 2025

Failid

  • 📎EUCanScreen Governmental Advisory Board (GAB) technical arrangements.msg133 KB
  • 📎GAB delegate_Estonia.pdf286 KB

Sisu (failidest)

Saatja: EUCanScreen Joint Action <[email protected]> Saaja: Made Bambus, Info - SOM, Maria Suurna, Kadi-Liis Veiman, Kaire Innos Teema: EUCanScreen Governmental Advisory Board (GAB) technical arrangements Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Dear Made, On behalf of the Governmental Advisory Board (GAB) and the EUCanScreen project coordination team, we acknowledge that Estonia has nominated Made Bambus, Maria Suurna and Kadi-Liis Veiman as delegates to represent your country in the GAB for the EUCanScreen project. To proceed with the necessary arrangements for the establishment of the GAB, we kindly request that the competent authority in Estonia confirms which of the nominated delegates will serve as the primary representative and which will serve as the alternate representative. Please provide us with this confirmation at your earliest convenience but not later than 25 February, so we can finalise the preparations for an upcoming GAB meeting in Turin, Italy, on 13 May 2025. We look forward to your confirmation and to working closely with you on this important project. Sincerely, Trude Andreassen Chair of the Governmental Advisory Board (GAB) Laura Stalidzane Project Manager [email protected] <mailto:[email protected]> From: Made Bambus - SOM <[email protected]> Sent: Monday, January 27, 2025 4:13 PM To: EUCanScreen Joint Action <[email protected]> Cc: Info - SOM <[email protected]>; Maria Suurna <[email protected]>; Kadi-Liis Veiman <[email protected]> Subject: Nomination of Delegates for the Joint Action EUCanScreen Governmental Advisory Board Dear Laura I hope this message finds you well. On behalf of the Estonian delegation, I am pleased to formally nominate the following persons to represent Estonia in the EUCanScreen Government Advisory Board: 1. Made Bambus, Adviser, The Ministry of Social Affairs [email protected] <mailto:[email protected]> 2. Maria Suurna, Service manager for screening, The Health Insurance Fund [email protected] <mailto:[email protected]> 3. Kadi-Liis Veiman, Project Manager, Estonian Cancer Center [email protected] <mailto:[email protected]> Kind regards Made Bambus adviser | Department of Health Services 5915 7973 | [email protected] ESTONIA Sotsiaalministeerium Suur-Ameerika 1 | 10122 Tallinn 626 9301 | http://www.sm.ee <http://www.sm.ee/et> From: EUCanScreen Joint Action <[email protected] <mailto:[email protected]> > Sent: Monday, January 27, 2025 2:04 PM To: Made Bambus - SOM <[email protected] <mailto:[email protected]> > Cc: Kaire Innos <[email protected] <mailto:[email protected]> > Subject: Reminder: Nomination of Delegates for the Joint Action EUCanScreen Governmental Advisory Board Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Dear Ms Bambus, This is a kind reminder regarding the invitation letter we sent earlier concerning the nomination of delegates for the Joint Action EUCanScreen Governmental Advisory Board (GAB). The letter outlines the important role of the GAB in supporting the implementation of evidence-based cancer screening programmes and provides details on the nomination process. We kindly ask you to submit the names and contact information of your nominated delegates by the end of January 2025 to [email protected] <mailto:[email protected]> . If you have any questions or require further clarification, please do not hesitate to get in touch. Best regards, Laura Stalidzane -------------------------- University of Latvia The Institute of Clinical and Preventive Medicine EUCanScreen Project Manager Phone: (+371) 28625489 E-mail: [email protected] <mailto:[email protected]> Central project email: [email protected] <mailto:[email protected]> From: EUCanScreen Joint Action Sent: Friday, January 10, 2025 12:41 PM To: '[email protected]' <[email protected] <mailto:[email protected]> > Cc: '[email protected]' <[email protected] <mailto:[email protected]> > Subject: Invitation to nominate delegates for the EUCanScreen GAB Dear Ms Bambus, Please find attached an invitation letter regarding the nomination of delegates for the Joint Action EUCanScreen Governmental Advisory Board (GAB). The letter outlines the role of the GAB in supporting the implementation of evidence-based cancer screening programmes and provides details on the nomination process. We kindly ask you to submit the names and contact information of your nominated delegates by the end of January 2025 to [email protected] <mailto:[email protected]> . Should you have any questions or require further information, please do not hesitate to contact us. Best regards, Laura Stalidzane -------------------------- University of Latvia The Institute of Clinical and Preventive Medicine EUCanScreen Project Manager Phone: (+371) 28625489 E-mail: [email protected] <mailto:[email protected]> Central project email: [email protected] <mailto:[email protected]> Riga, 10 January 2025 To: Ms Made Bambus, the Ministry of Social Affairs, Estonia Invitation to Nominate Delegates for the EUCanScreen Governmental Advisory Board (GAB) The European Joint Action EUCanScreen is aiming at reducing the burden of cancer in Europe through effective and sustainable cancer screening programs. The activities have been planned to ensure full implementation of evidence- based, cost-effective and quality-assured screening programmes for breast, cervical and colorectal cancers across the EU as well as preparing for possible implementation of evidence-based, cost-effective and quality-assured screening programmes for lung, prostate and gastric cancers. Ensuring proper program governance and sustainability is an important factor to be addressed by the Joint Action. The outcomes of EUCanScreen are highly depending on the involvement and support of the decision-makers in the Member States. To assure maximum gain from the project while implementing the project outcomes, support from the responsible specialists within the Ministries responsible for cancer screening is a prerequisite. The establishment of a Governmental Advisory Board (GAB) is therefore planned to support these endeavours and facilitate communication between the decision-makers in Member States. Therefore, on behalf of EUCanScreen we ask each of the EU Member States as well as other countries participating in EUCanScreen to delegate between 2 and 3 representatives (one representative and one deputy as the minimum) from the responsible ministry, or other similar institutions, with expertise in cancer 1 screening for participation in the GAB. The Governmental Advisory Board will be a vital component of the EUCanScreen project. It will serve as a platform to engage political decision-makers and funding authorities in shaping national strategies and governance structures that align with the 2022 EU Council Recommendation on Cancer Screening, Europe’s Beating Cancer Plan, and the WHO’s goal for the elimination of cervical cancer. We expect delegates to participate in virtual meetings held twice a year, along with 1-2 in-person meetings over the next three years. Additionally, they will be responsible for sharing the acquired information within their respective ministries and at the national level. Please send the names and the contacts of the suggested delegates before the end of January 2025 to [email protected]. Director of the Institute of Clinical and Preventive Medicine of the University of Latvia, Mārcis Leja Scientific Project Manager of the EUCanScreen Project 2
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel